FDAFDA · Food and drugs·Recall number D-1327-2015
Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius Kabi USA 2020 N Ruby Street, Melrose Park, IL 60160-1112 for Fresenius Kabi USA, 3 Corporate Dr Lake Zurich, IL 60047-8930. NDC 63323-614-01
Published August 19, 2015 · Recall initiated: July 28, 2015
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HYDRALAZINE HYDROCHLORIDE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide
- UPC
- 0363323614003
- Lot
- Lot #: 6110593, Exp 11/2016
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.